TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Recipharm AB
Closing information (x1000 EUR)
Closing information | 2021/12 | 2020/12 (consolidated) | 2019/12 (consolidated) |
Turnover | 24,237 | 1,102,725 | 714,720 |
Financial expenses | 160,143 | 53,519 | 21,067 |
Earnings before taxes | 7,706 | 49,654 | 35,664 |
EBITDA | -24,311 | 194,341 | 119,010 |
Total assets | 1,698,287 | 2,155,696 | 1,318,989 |
Current assets | 244,110 | 603,298 | 404,846 |
Current liabilities | 162,613 | 334,954 | 149,910 |
Equity capital | 690,999 | 732,722 | 545,421 |
- share capital | 4,944 | 3,377 | 3,249 |
Employees (average) | 64 | 7,857 | 5,316 |
Financial ratios
Fiscal year | 2021/12 | 2020/12 (consolidated) | 2019/12 (consolidated) |
Solvency | 40.7% | 34.0% | 41.4% |
Turnover per employee | 379 | 140 | 134 |
Profit as a percentage of turnover | 31.8% | 4.5% | 5.0% |
Return on assets (ROA) | 9.9% | 4.8% | 4.3% |
Current ratio | 150.1% | 180.1% | 270.1% |
Return on equity (ROE) | 1.1% | 6.8% | 6.5% |
Change turnover | |||
Change turnover % | 48% | 17% | |
Chg. No. of employees | |||
Chg. No. of employees % | 48% | 10% |
Total value of public sale
Fiscal year | 2021/12 | 2020/12 (consolidated) | 2019/12 (consolidated) |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.